NDC 0002-7623

Alimta

Pemetrexed Disodium

Alimta is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Pemetrexed Disodium Heptahydrate.

Product ID0002-7623_2ae8f881-3b72-4494-9285-9c9ad4ea1148
NDC0002-7623
Product TypeHuman Prescription Drug
Proprietary NameAlimta
Generic NamePemetrexed Disodium
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2004-02-04
Marketing CategoryNDA / NDA
Application NumberNDA021462
Labeler NameEli Lilly and Company
Substance NamePEMETREXED DISODIUM HEPTAHYDRATE
Active Ingredient Strength500 mg/20mL
Pharm ClassesFolate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0002-7623-01

1 VIAL in 1 CARTON (0002-7623-01) > 20 mL in 1 VIAL
Marketing Start Date2004-02-13
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0002-7623-61 [00002762361]

Alimta INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021462
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-07-24
Marketing End Date2015-03-30

NDC 0002-7623-01 [00002762301]

Alimta INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA021462
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2004-02-13

Drug Details

Active Ingredients

IngredientStrength
PEMETREXED DISODIUM HEPTAHYDRATE500 mg/20mL

OpenFDA Data

SPL SET ID:f5a860f3-37ec-429c-ae04-9c88d7c55c08
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1728079
  • 1728072
  • 1728075
  • 1728077

    • Pharmacological Class

    • Folate Analog Metabolic Inhibitor [EPC]
    • Folic Acid Metabolism Inhibitors [MoA]

    NDC Crossover Matching brand name "Alimta" or generic name "Pemetrexed Disodium"

    NDCBrand NameGeneric Name
    0002-7623AlimtaPemetrexed disodium
    0002-7640AlimtaPemetrexed disodium
    0781-3518PemetrexedPemetrexed disodium
    0781-3519PemetrexedPemetrexed disodium
    0781-3520PemetrexedPemetrexed disodium
    16729-522PemetrexedPemetrexed disodium
    50742-340PemetrexedPemetrexed disodium
    50742-341PemetrexedPemetrexed disodium
    60505-6065PemetrexedPemetrexed disodium
    60505-6066PemetrexedPemetrexed disodium
    60505-6067PemetrexedPemetrexed disodium
    60505-6068PemetrexedPemetrexed disodium
    63323-134PemetrexedPEMETREXED DISODIUM
    63323-450PemetrexedPEMETREXED DISODIUM
    63323-621PemetrexedPEMETREXED DISODIUM
    63323-622PemetrexedPEMETREXED DISODIUM
    67184-0503PemetrexedPemetrexed disodium
    67184-0504PemetrexedPemetrexed disodium
    68001-538PemetrexedPemetrexed disodium
    68001-539PemetrexedPemetrexed disodium
    68001-543PemetrexedPemetrexed disodium
    68001-544PemetrexedPemetrexed disodium
    68001-550PemetrexedPemetrexed disodium
    68001-551PemetrexedPemetrexed disodium
    68001-552PemetrexedPemetrexed disodium
    43598-370Pemetrexed disodiumPemetrexed disodium
    43598-386Pemetrexed disodiumPemetrexed disodium
    43598-387Pemetrexed disodiumPemetrexed disodium

    Trademark Results [Alimta]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ALIMTA
    ALIMTA
    75427790 2414358 Live/Registered
    Eli Lilly and Company
    1998-02-02
    © 2025 FDA.report
    This site is not affiliated with or endorsed by the FDA.